Shopping Cart
- Remove All
- Your shopping cart is currently empty
IXA62 is an orally active, selective IRE1/XBP1s agonist (EC50= 0.31 μM) that can reduce Aβ secretion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | IXA62 is an orally active, selective IRE1/XBP1s agonist (EC50= 0.31 μM) that can reduce Aβ secretion. |
In vitro | IXA62 is a selective activator of IRE1/XBP1s that reduces Aβ secretion in CHO 7PA2 cells and enhances glucose-stimulated insulin secretion in rat insulinoma cells, demonstrating effects similar to IXA4 in these experiments. |
In vivo | IXA62 (orally or i.p, 50 mg/kg) robustly and selectively activates the IRE1/XBP1s signaling pathway in the liver of mice. |
Molecular Weight | 401.458 |
Formula | C24H23N3O3 |
Cas No. | 956783-34-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.